June 20, 2022 — Clinical trials of new gel treatments for stroke should be delayed until technology used in the tests is ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
June 14, 2022 — A new American Heart Association scientific statement highlights the need for more data and research ...
June 10, 2022 — Individuals with diabetes display a substantially increased risk of disease in left-sided heart valves c ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
June 9, 2022 — Memorial Regional Hospital recently entered elite company, becoming just the fourth hospital in the ...
June 8, 2022 — The U.S. Food and Drug Administration (FDA) has issued a release stating that Medtronic is recalling the ...
June 3, 2022 — Texas Children's Hospital patient Garrett Richardson, 21, is alive today because his quick-thinking ...
Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...
June 1, 2022 — Biofourmis, a Boston-based global leader in virtual care and digital medicine, announced that its ...
June 1, 2022 — Eating low glycaemic index foods promotes a healthier body shape in patients with coronary artery disease ...
June 1, 2022 — Recardio's Phase 2 trial results demonstrated the excellent safety profile of its lead drug Dutogliptin ...
May 31, 2022 — Findings from the XARELTO (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and ...
May 31, 2022 — Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure ...
May 26, 2022 — Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced ...
May 26, 2022 — For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol ...
June 20, 2022